The TRT market has clearly stabilized - and Axiron appears to be making a gradual uptick... will hold off calling this a return to growth until another couple of quarter results.
They are starting to focus on expanding the pipeline - the messaging is better and more positive... the idea that this is a fully funded biotech is a good one and they do have some interesting IP / areas of focus here.... Now its time to deliver on these!!!
Ann: 2015 AGM Presentation and Script, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
